AKRO - Akero Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AKRO is currently covered by 6 analysts with an average price target of $80.85. This is a potential upside of $26.2 (47.94%) from yesterday's end of day stock price of $54.65.

Akero Therapeutics's activity chart (see below) currently has 104 price targets and 78 ratings on display. The stock rating distribution of AKRO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.44% with an average time for these price targets to be met of 316.18 days.

Highest price target for AKRO is $109, Lowest price target is $54, average price target is $79.4.

Most recent stock forecast was given by PRAKHAR AGRAWAL from CANTOR FITZGERALD on 10-Dec-2025. First documented stock forecast 15-Jul-2019.

Currently out of the existing stock ratings of AKRO, 11 are a BUY (100%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 19-Sep-2023

30 days ago
(10-Dec-2025)

1/4 (25%)

$29.93 (96.33%)

474

Buy

Since 10-Feb-2020

$54

$-0.65 (-1.19%)

$73

3 months ago
(09-Oct-2025)

6/9 (66.67%)

$-0.08 (-0.15%)

375

Buy

Since 12-Jun-2023

$84

$29.35 (53.71%)

$90

7 months 28 days ago
(12-May-2025)

3/8 (37.5%)

$42.47 (102.26%)

350

Buy

Since 02-Mar-2020

$75

$20.35 (37.24%)

$72

10 months 6 days ago
(03-Mar-2025)

12/25 (48%)

$29.46 (64.69%)

265

Buy

Since 28-Aug-2023

$109

$54.35 (99.45%)

$42

11 months 9 days ago
(31-Jan-2025)

2/4 (50%)

$54.92 (101.55%)

401

Show more analysts

Please expand the browser size to see the chart

What is AKRO (Akero Therapeutics) average time for price targets to be met?

On average it took 316.18 days on average for the stock forecasts to be realized with a an average price target met ratio 54.44

Which analyst has the current highest performing score on AKRO (Akero Therapeutics) with a proven track record?

EDWARD NASH

Which analyst has the most public recommendations on AKRO (Akero Therapeutics)?

Edward Nash works at CANACCORD and has 3 price targets and 4 ratings on AKRO

Which analyst is the currently most bullish on AKRO (Akero Therapeutics)?

Eliana Merle with highest potential upside - $54.35

Which analyst is the currently most reserved on AKRO (Akero Therapeutics)?

Liisa Bayko with lowest potential downside - -$16.65

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?